Final Exam Study Guide MDD/SI •SI lethality – remember plan and intent •Diagnostic differences of MDD in pediatric vs. adults •FDA approved meds for MDD •Leading cause of death in ages 15-24 (MVA, SI, HI) ADHD •Assessment to obtain prior to starting stimulants •First-line treatment •Family hx of Substance Use Disorder – consider Atomoxetine, clonidine, guanfacine •Monitoring while on stimulants – nutrition, sleep etc. Substance Use Disorders •Psychosocial risk factors vs. protective factors – In Sadock textbook Schizophrenia NOTE: There is often a premorbid history of behavioral disturbances, delayed milestones etc. •How does thought blocking manifest clinically? •Weight gaining vs. weight neutral antipsychotics •Symptoms in prodromal phase – most severe (positive vs. negative?)
